Waverley Pharma Inc V.WAVE

Healthcare Biotechnology

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.

TSXV:WAVE - Post by User

Waverley Pharma Inc > FACTS

<< Previous

Bullboard Posts

Next >>

Post by NEMOMEIMPUNEon Mar 31, 2021 8:14am

289 Views

Post# 32912450

FACTS

To underpin my earlier posts.
When searching "Owner of shares in WAVE".
The following emerge:

Total amounts of shares: 54.000 000 (almost all of it belongs to Dr. Friesen... bar 122 000 units)
Share holdings of management: 40.414 000
Share holdings of "institutions": 4.773 000 + 3.997 000 ( they will not sell at these low values)
Shares that I will not sell: 330.000

Left to fight about: 4.486 000

WHAT DO YOU THINK WILL HAPPEN ??

NEMO

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features